Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Influential Women Features Vita Oyler: Champions Resilience Through Chronic Pain Rehabilitation And Holistic Wellness
EIN Presswire
CALIFORNIA, CA, UNITED STATES, September 30, 2026 /EINPresswire.com/ -- A Lifelong Commitment To Helping Others Find Practical Paths Forward California – With more than 35 years of experience in rehabilitation counseling, Vita Oyler has...
Italfarmaco Presents New Givinostat (Duvyzat®) Clinical Data Supporting Preservation of Upper Limb Function in Duchenne Muscular Dystrophy Patients at the 2026 World Muscle Society Congress
GlobeNewswire, Inc.
New data suggest that givinostat treatment may slow the decline of upper limb function in boys with Duchenne muscular dystrophy compared with modelled external comparator disease trajectories derived from a single centre natural history study...
Santhera Pharmaceuticals Half Year Results for the six months ending 30 June 2026
GlobeNewswire, Inc.
Ad hoc announcement pursuant to Art. 53 LR. A conference call will be held on September 30, 2026, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release Strong momentum and expanding global access position AGAMREE® for...
Global Software as a Medical Device Market to Observe Stupendous Growth at a CAGR of ~17% by 2034 | DelveInsight
GlobeNewswire, Inc.
New York, USA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Global Software as a Medical Device Market to Observe Stupendous Growth at a CAGR of ~17% by 2034 | DelveInsight The software as a medical device market is experiencing strong growth, driven by the...
VCD Medical Receives U.S. FDA 510(k) Clearance for VEnice™ Vein Closure Device
GlobeNewswire, Inc.
Brescia, Italy, Sept. 29, 2026 (GLOBE NEWSWIRE) -- VCD Medical, an Italy-based company developing novel, minimally invasive vein closure technologies, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its VEnice™ Vein...
NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease
GlobeNewswire, Inc.
- SPINOZA is studying obicetrapib in adults with biomarker evidence suggestive of preclinical Alzheimer’s disease who do not have noticeable memory or functional symptoms- - The study will evaluate changes in blood-based biomarkers associated with...
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business
GlobeNewswire, Inc.
ROSELAND, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a medical technology company specializing in advanced computerized injection and drug-delivery technologies, today highlighted continued progress...
4BIO Capital leads €40 Million ($45M) seed financing of Aptadir Therapeutics to advance first-in-class demethylating medicines
GlobeNewswire, Inc.
Funds will advance novel class of RNA inhibitors to reverse intractable genetic conditions Seed led by 4BIO Capital with follow-on participation from the company's original pre-seed investor EXTEND (CDP Venture Capital SGR, Angelini Ventures and...
APTADIR RAISES A €40M ($45M) SEED FINANCING TO ADVANCE FIRST-IN-CLASS DEMETHYLATING MEDICINES
GlobeNewswire, Inc.
Funds will advance novel class of RNA inhibitors to reverse intractable genetic conditions Seed is led by 4BIO Capital with follow-on participation from the company's original pre-seed investor EXTEND (CDP Venture Capital SGR, Angelini Ventures...
Live Whole Health #336: Spaghetti squash is your fall must-try
U.S. Department of Veterans Affairs
Autumn harvest: Rediscovering spaghetti squash As the air turns crisp and leaves begin to fall, I find myself drawn to local farms and markets in search of seasonal treasures—apples, pumpkins and spaghetti squash.
Acne Vulgaris Market Set for Significant Growth During the Forecast Period (2026–2036), Amid Rising Disease Burden and Therapeutic Advances | DelveInsight
GlobeNewswire, Inc.
New York, USA, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Acne Vulgaris Market Set for Significant Growth During the Forecast Period (2026–2036), Amid Rising Disease Burden and Therapeutic Advances | DelveInsight The acne vulgaris market is expected to...
Alex Bodi and Prof. Dr Dieter Lazik sign a contract for ALPHA WHEY and BODI Energy Drink
GlobeNewswire, Inc.
Hamburg, Germany, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Alex Bodi is relying on scientific collaboration and international partnerships to build up ALPHA WHEY and BODI Energy Drink.
Chinese Brands Going Global — Worldwide Tour (Europe Stop) holds events in Switzerland, Italy
GlobeNewswire, Inc.
MILAN, Sept. 26, 2026 (GLOBE NEWSWIRE) -- On September 23, 2026, local time, the Consulate General of the People's Republic of China in Milan hosted a reception marking the 77th anniversary of the founding of the People's Republic of China.
Pharmacovigilance Market to reach USD 32.13 Billion by 2035 at 12.5% CAGR
EIN Presswire
Pharmacovigilance Market to Surge from USD 9.96 Bn in 2025 to $32.13 Bn by 2035—Complex Modalities Rewriting Safety Economics, Regulatory Timelines Compressing NY, CA, UNITED STATES, September 22, 2026 /EINPresswire.com/ -- As per Market...
Clinical Fine Line Reduction for Medical Aesthetics: ENDO ONE on Full-Face Laxity and Patient-Specific Protocols
EIN Presswire
POZZUOLI, NA, ITALY, September 22, 2026 /EINPresswire.com/ -- Aesthetic medical practices face a growing demographic of patients seeking natural facial rejuvenation that eliminates superficial rhytids and restores skin elasticity without...
Sanders Announces $54.6 Million Awarded in Rural Health Transformation Funds
Arkansas Governor
LITTLE ROCK, Ark.— Governor Sarah Huckabee Sanders today announced $54.6 million in awards to recipients of the second round of Rural Health Transformation Program (RHTP) grants, established through President Donald J. Trump’s One, Big, Beautiful...
Global Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight
GlobeNewswire, Inc.
New York, USA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Global Autoimmune Disease Therapeutics Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight The autoimmune disease therapeutics market is experiencing steady growth, driven by the...
Terra Innovatum Welcomes Italy’s Historic Return to Nuclear Energy
GlobeNewswire, Inc.
Italy’s new nuclear framework underscores growing European momentum behind advanced nuclear technologies, including small and micro-modular reactors At the 70th IAEA General Conference, Italy showcased Terra Innovatum’s SOLO™ as the country’s...
Qosina Supports MedTech Collaboration as Sponsor of the 2026 MPO Summit
GlobeNewswire, Inc.
Ronkonkoma, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Qosina, a global partner supplying components, custom solutions and regulatory services for the medical device and life sciences industries, is proud to sponsor the 2026 MPO Summit, taking place...
Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment
GlobeNewswire, Inc.
HEIDELBERG, Germany, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Belgian biopharmaceutical company Flen Health has selected AGC Biologics as their CDMO partner to provide process development, scale-up, and GMP manufacturing services for a new and improved...
Sign up for:
Health Watch Italy
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.